Discover 2,409 paid clinical trials in Naperville, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,409
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
for
Hypoplastic Left Heart Syndrome (HLHS)
Location: Oak Lawn IL, Chicago IL, Milwaukee WI, Madison WI,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0 - 1
Code: NCT02852031
Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Oak Lawn IL, Park Ridge IL, Chicago IL, Milwaukee WI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase 3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Oak Lawn IL, Park Ridge IL, Chicago IL, Milwaukee WI,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
Standardized Application of Feeding Evaluations Using SMART Tool
for
Infant and Young Child Feeding
Location: Oak Lawn IL, Elgin IL, Park Ridge IL, Chicago IL,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 0 - 1
Code: NCT07136610
Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Oak Lawn IL, Park Ridge IL, Chicago IL, Milwaukee WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
for
Germ Cell Tumor
Location: Oak Lawn IL, Park Ridge IL, Chicago IL, St Louis MO,
Sponsor: University of Sydney
Sex: All
Age: 11 - 50
Code: NCT02582697
Phase 3, Recruiting
Association of Near Infrared Spectroscopy With Interstage Outcomes
for
Single-ventricle
Location: Oak Lawn IL
Sponsor: Advocate Hospital System
Sex: All
Age: 0
Code: NCT06538571
Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Oak Lawn IL, Chicago IL, Milwaukee WI, Peoria IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Oak Lawn IL, Park Ridge IL, Chicago IL, Milwaukee WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 30
Code: NCT06172296
Phase 3, Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Oak Lawn IL, Park Ridge IL, Chicago IL, Milwaukee WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase 2, Recruiting
Confirmation Trial of the Acorn CorCap Cardiac Support Device (CSD) at the Same Time as Mitral Valve Repair
for
Heart Failure
Location: Oak Lawn IL, Ann Arbor MI, Detroit MI, Cleveland OH,
Sponsor: Acorn Cardiovascular, Inc.
Sex: All
Age: 18 - 70+
Code: NCT00630266
Phase 2, Recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Location: Oak Forest IL, Carmel IN, Nashville TN, Hagerstown MD,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 50+
Code: NCT05197270
Phase 1, Phase 2, Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Niles IL, Ann Arbor MI, St Louis MO, Louisville KY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase 3, Recruiting
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for
Biliary Tract Cancer
Location: Niles IL, Chicago IL, Grand Rapids MI, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06467357
Phase 3, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2